Physician profile
Ashraf M Elsayegh
NPI 1073684056
$104,230.73
in general payments reported to CMS, 2019-2025
47 companies · $6,482 in 2025
The $6,482 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,266 · 2020: $3,703 · 2021: $5,780 · 2022: $16K · 2023: $21K · 2024: $48K · 2025: $6,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Travel and Lodging: $12K · Food and Beverage: $8,089 · Education: $2,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,780.00 |
| Travel and Lodging | $12,284.82 |
| Food and Beverage | $8,089.00 |
| Education | $2,594.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $74,865.90 | 2021-2024 | Veklury |
| Insmed, INC. | $7,052.78 | 2022-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $4,055.46 | 2019-2024 | Yupelri, Yupelri |
| Intuitive Surgical, INC. | $2,906.58 | 2025 | |
| Hill-Rom Company, INC | $1,760.00 | 2021 | |
| Inspire Medical Systems, INC. | $1,686.42 | 2024-2025 | Inspire |
| Baxter Healthcare | $1,006.22 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Allergan, INC. | $981.39 | 2019-2020 | |
| Tanabe Pharma America, INC. | $810.79 | 2019-2025 | Radicava |
| Paratek Pharmaceuticals, INC. | $776.18 | 2020-2025 | Nuzyra |
| Astrazeneca Pharmaceuticals Lp | $717.62 | 2019-2025 | Tezspire, Andexxa, Fasenra |
| Mallinckrodt Hospital Products INC. | $558.87 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $518.59 | 2019-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $471.84 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Grifols USA, LLC | $405.08 | 2019-2025 | Prolastin-C Liquid |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $390.38 | 2022-2025 | Tezspire |
| Advanced Respiratory, INC | $378.21 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $377.40 | 2021-2025 | |
| Galvanize Therapeutics, INC | $364.36 | 2025 | Aliya System |
| Hill-Rom Services, INC | $360.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $351.22 | 2021-2024 | Dupixent, Evkeeza |
| Electromed, INC. | $337.15 | 2021-2025 | Smartvest |
| Genzyme Corporation | $306.17 | 2022-2025 | |
| Mallinckrodt Enterprises LLC | $226.78 | 2019 | |
| Merck Sharp & Dohme LLC | $216.89 | 2019-2024 | Zerbaxa |
| United Therapeutics Corporation | $203.07 | 2022-2025 | Tyvaso, Tyvaso |
| La Jolla Pharmaceutical Company | $198.29 | 2022-2024 | Giapreza |
| Shionogi INC | $190.60 | 2021-2025 | Fetroja |
| Actelion Pharmaceuticals US, INC. | $185.53 | 2022-2025 | Uptravi, Opsumit |
| Harmony Biosciences LLC | $177.91 | 2020-2021 | |
| Csa Medical, INC | $159.28 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.99 | 2020-2021 | |
| Ventec Life Systems, INC. | $154.04 | 2021 | |
| Philips North America LLC | $151.39 | 2019-2024 | (Ak6) Vest Therapy |
| Nabriva Therapeutics, Plc | $107.05 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $97.46 | 2019 | |
| Avanir Pharmaceuticals, INC. | $96.21 | 2021-2022 | |
| Pulmonx Corporation | $79.96 | 2022-2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Biogen, INC. | $64.62 | 2022-2023 | Spinraza |
| Alexion Pharmaceuticals, INC. | $62.21 | 2021-2023 | Ultomiris |
| Ani Pharmaceuticals, INC. | $48.54 | 2022 | |
| Pfizer INC. | $46.08 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $45.43 | 2023-2024 | Nuedexta |
| Depuy Synthes Sales INC. | $44.21 | 2023 | Conduit |
| Verona Pharma, INC. | $39.51 | 2025 | Ohtuvayre |
| Idorsia Pharmaceuticals US INC | $24.03 | 2022 | |
| Viiv Healthcare Company | $16.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashraf Elsayegh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.